from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3399/-

LFCtreatmentdescriptionclass of inhibitor

1.174

Amikacinug/mL Amikacintranslation

0.593

Cap5-10ug/mL Capreomycintranslation

0.737

Rox10-50 ug/mL Roxithromycintranslation

0.777

SM2-5 ug/mL Streptomycintranslation

0.530

Tet5-10 ug/mL Tetracyclinetranslation

0.473

Rif0.2-5ug/mL Rifampicintranscription

0.381

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.628

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.343

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.286

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.019

Clofazimine10-13 ug/mL Clofaziminerespiration

0.715

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.118

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.026

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.892

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.186

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.179

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.029

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.300

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.721

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

1.101

Nigericin50 uM Nigericinrespiration

-0.417

TRC10-150 ug/mL Triclosanrespiration

2.264

TRZ10-25 ug/mL Thioridazinerespiration

1.264

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.466

menadione6-10 ug/mL Menadionerespiration

-0.233

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.030

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.199

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.488

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.803

NRP_1Non-replicating persistence stage 1dosRassociated

0.028

Amp0.2mg/mL AmpicillincellWall

-0.265

Cephalexin20-100 ug/mL CephalexincellWall

-0.085

Cerulenin0.32-5 ug/mL CerulenincellWall

0.253

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.752

EMB10-20 ug/mL EthambutolcellWall

1.110

Eta12-40 ug/mL EthionamidecellWall

0.141

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.099

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.316

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.567

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.342

BZA0.12 mg/mL BenzamidearomaticAmides

-0.420

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.043

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.308

H2O24 mM hydrogen peroxideDNAdamaging

-0.261

Levo10 ug/mL LevofloxacinDNAdamaging

-0.193

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.054

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.757

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.223

UVUV-irradiationDNAdamaging

-0.617

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.169

Antimycin12.5-50 ug/mL Antimycin A?

-0.472

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.406

PA_110-50 ug/mL Antitubercular compound PA-1?

0.191

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.796

PA8240.2-2 ug/mL PA-824?

0.336

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.114

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.522

Verapamil50 uM Verapamil?

0.676

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.694

methoxatin10-20 ug/mL Methoxatin?